Pathological diagnoses are becoming a very complicated medical field due to the advent of many different biomarker needs both for the identification of histological and molecular oncogene targets and immunotherapy-related bioselectors (i.e. PD-1/PD-L1 axis).
The CME meeting will host 4 “MASTERS” in pathology and thanks to the application of an innovative digital pathology platform will offer to the participants the unique possibility of exploring the crucial diagnostic criteria of the following pivotal fields:
● Breast pathology
● Gastrointestinal pathology
● Cytopathology
● Soft tissue pathology
This educational meeting will explore, through discussion of challenging real pathological clinical cases diagnosed according to the latest cancer diagnostic criteria, including extensive molecular characterization by NGS and omics, several possible diagnostic patterns.
The course will gather participants from all over the world with the main objective to get participants in the "navigation" of cases by world opinion leaders to stimulate the consolidation of diagnostic skills through the development of strategic thinking.
Cases will be selected through integration of clinical-pathological data with the mutational landscape and the immunological background/status of the patients for a representative overview of the difficult diagnostic process in oncology and immunosoppression context.
Through innovative digital pathology technological approaches, the cases will be presented in a manner that allows the fundamental diagnostic and management aspects to be addressed. While viewing the cases, participants will be able to challenge themselves on dilemmas posed by the speakers in quizzes that will engage them in an interactive manner increasing learning and participation.